Hormones & Cancer-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2157808, encodeId=73ae215e80826, content=Initial technical check都21天了，还没有动静。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Iiaml2UbHXGORLCB6yjcA3siahzkAlrsL10ic5HpBKNzEaOJvOKpYqH5MWzYASOgMkP6AsOtibp1K0XXosBKjSA7sg/132, createdBy=c3382256530, createdName=喵喵.com, createdTime=Fri Sep 15 09:59:57 CST 2023, time=2023-09-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2144610, encodeId=049821446109e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析 经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Sun Jun 25 10:58:25 CST 2023, time=2023-06-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2176067, encodeId=55b921e6067a9, content=审稿速度:6.0 经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee235687562, createdName=ms9000001505387034, createdTime=Wed Dec 20 10:44:25 CST 2023, time=2023-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2146705, encodeId=39872146e05a1, content=想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26c88438756, createdName=ms7000000619671915, createdTime=Thu Jul 06 22:46:50 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2151710, encodeId=fa382151e103d, content=比较慢，并不是官方公布的那样。甚至第一关技术审查都不知道多久。着急的战友可绕道。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/14/b3e81e46eebeced4f1fa35ba3f571f1b.jpg, createdBy=eb0a2196272, createdName=湛湛518, createdTime=Tue Aug 08 00:41:04 CST 2023, time=2023-08-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1248225, encodeId=9acf1248225fe, content=请问更名后，检索得出来吗？推荐转投的，有点怕。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a7f5533568, createdName=韦钰, createdTime=Fri Sep 09 22:38:17 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174835, encodeId=16b621e483509, content=偏重的研究方向：肿瘤 经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd069039656, createdName=ms6000000198285398, createdTime=Thu Dec 14 00:06:56 CST 2023, time=2023-12-14, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2174396, encodeId=599521e4396eb, content=开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a24661695, createdName=liangshoulei, createdTime=Tue Dec 12 09:35:51 CST 2023, time=2023-12-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2161318, encodeId=48c02161318d8, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：审稿速度特慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Oct 07 12:04:42 CST 2023, time=2023-10-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=949365, encodeId=6c1094936573, content=已经更名为discovery oncology, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 18 22:08:28 CST 2021, time=2021-03-18, status=1, ipAttribution=)]

2023-09-15 喵喵.com 来自陕西省

Initial technical check都21天了，还没有动静。。。

51 23

展开23条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157808, encodeId=73ae215e80826, content=Initial technical check都21天了，还没有动静。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Iiaml2UbHXGORLCB6yjcA3siahzkAlrsL10ic5HpBKNzEaOJvOKpYqH5MWzYASOgMkP6AsOtibp1K0XXosBKjSA7sg/132, createdBy=c3382256530, createdName=喵喵.com, createdTime=Fri Sep 15 09:59:57 CST 2023, time=2023-09-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2144610, encodeId=049821446109e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析 经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Sun Jun 25 10:58:25 CST 2023, time=2023-06-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2176067, encodeId=55b921e6067a9, content=审稿速度:6.0 经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee235687562, createdName=ms9000001505387034, createdTime=Wed Dec 20 10:44:25 CST 2023, time=2023-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2146705, encodeId=39872146e05a1, content=想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26c88438756, createdName=ms7000000619671915, createdTime=Thu Jul 06 22:46:50 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2151710, encodeId=fa382151e103d, content=比较慢，并不是官方公布的那样。甚至第一关技术审查都不知道多久。着急的战友可绕道。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/14/b3e81e46eebeced4f1fa35ba3f571f1b.jpg, createdBy=eb0a2196272, createdName=湛湛518, createdTime=Tue Aug 08 00:41:04 CST 2023, time=2023-08-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1248225, encodeId=9acf1248225fe, content=请问更名后，检索得出来吗？推荐转投的，有点怕。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a7f5533568, createdName=韦钰, createdTime=Fri Sep 09 22:38:17 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174835, encodeId=16b621e483509, content=偏重的研究方向：肿瘤 经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd069039656, createdName=ms6000000198285398, createdTime=Thu Dec 14 00:06:56 CST 2023, time=2023-12-14, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2174396, encodeId=599521e4396eb, content=开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a24661695, createdName=liangshoulei, createdTime=Tue Dec 12 09:35:51 CST 2023, time=2023-12-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2161318, encodeId=48c02161318d8, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：审稿速度特慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Oct 07 12:04:42 CST 2023, time=2023-10-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=949365, encodeId=6c1094936573, content=已经更名为discovery oncology, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 18 22:08:28 CST 2021, time=2021-03-18, status=1, ipAttribution=)]

2023-06-25 ms5000000525566741 来自河南省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析
经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙

36 22

展开22条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157808, encodeId=73ae215e80826, content=Initial technical check都21天了，还没有动静。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Iiaml2UbHXGORLCB6yjcA3siahzkAlrsL10ic5HpBKNzEaOJvOKpYqH5MWzYASOgMkP6AsOtibp1K0XXosBKjSA7sg/132, createdBy=c3382256530, createdName=喵喵.com, createdTime=Fri Sep 15 09:59:57 CST 2023, time=2023-09-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2144610, encodeId=049821446109e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析 经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Sun Jun 25 10:58:25 CST 2023, time=2023-06-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2176067, encodeId=55b921e6067a9, content=审稿速度:6.0 经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee235687562, createdName=ms9000001505387034, createdTime=Wed Dec 20 10:44:25 CST 2023, time=2023-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2146705, encodeId=39872146e05a1, content=想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26c88438756, createdName=ms7000000619671915, createdTime=Thu Jul 06 22:46:50 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2151710, encodeId=fa382151e103d, content=比较慢，并不是官方公布的那样。甚至第一关技术审查都不知道多久。着急的战友可绕道。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/14/b3e81e46eebeced4f1fa35ba3f571f1b.jpg, createdBy=eb0a2196272, createdName=湛湛518, createdTime=Tue Aug 08 00:41:04 CST 2023, time=2023-08-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1248225, encodeId=9acf1248225fe, content=请问更名后，检索得出来吗？推荐转投的，有点怕。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a7f5533568, createdName=韦钰, createdTime=Fri Sep 09 22:38:17 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174835, encodeId=16b621e483509, content=偏重的研究方向：肿瘤 经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd069039656, createdName=ms6000000198285398, createdTime=Thu Dec 14 00:06:56 CST 2023, time=2023-12-14, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2174396, encodeId=599521e4396eb, content=开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a24661695, createdName=liangshoulei, createdTime=Tue Dec 12 09:35:51 CST 2023, time=2023-12-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2161318, encodeId=48c02161318d8, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：审稿速度特慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Oct 07 12:04:42 CST 2023, time=2023-10-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=949365, encodeId=6c1094936573, content=已经更名为discovery oncology, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 18 22:08:28 CST 2021, time=2021-03-18, status=1, ipAttribution=)]

2023-12-20 ms9000001505387034 来自福建省

审稿速度:6.0
经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心

27 19

展开19条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157808, encodeId=73ae215e80826, content=Initial technical check都21天了，还没有动静。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Iiaml2UbHXGORLCB6yjcA3siahzkAlrsL10ic5HpBKNzEaOJvOKpYqH5MWzYASOgMkP6AsOtibp1K0XXosBKjSA7sg/132, createdBy=c3382256530, createdName=喵喵.com, createdTime=Fri Sep 15 09:59:57 CST 2023, time=2023-09-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2144610, encodeId=049821446109e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析 经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Sun Jun 25 10:58:25 CST 2023, time=2023-06-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2176067, encodeId=55b921e6067a9, content=审稿速度:6.0 经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee235687562, createdName=ms9000001505387034, createdTime=Wed Dec 20 10:44:25 CST 2023, time=2023-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2146705, encodeId=39872146e05a1, content=想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26c88438756, createdName=ms7000000619671915, createdTime=Thu Jul 06 22:46:50 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2151710, encodeId=fa382151e103d, content=比较慢，并不是官方公布的那样。甚至第一关技术审查都不知道多久。着急的战友可绕道。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/14/b3e81e46eebeced4f1fa35ba3f571f1b.jpg, createdBy=eb0a2196272, createdName=湛湛518, createdTime=Tue Aug 08 00:41:04 CST 2023, time=2023-08-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1248225, encodeId=9acf1248225fe, content=请问更名后，检索得出来吗？推荐转投的，有点怕。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a7f5533568, createdName=韦钰, createdTime=Fri Sep 09 22:38:17 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174835, encodeId=16b621e483509, content=偏重的研究方向：肿瘤 经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd069039656, createdName=ms6000000198285398, createdTime=Thu Dec 14 00:06:56 CST 2023, time=2023-12-14, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2174396, encodeId=599521e4396eb, content=开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a24661695, createdName=liangshoulei, createdTime=Tue Dec 12 09:35:51 CST 2023, time=2023-12-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2161318, encodeId=48c02161318d8, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：审稿速度特慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Oct 07 12:04:42 CST 2023, time=2023-10-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=949365, encodeId=6c1094936573, content=已经更名为discovery oncology, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 18 22:08:28 CST 2021, time=2021-03-18, status=1, ipAttribution=)]

2023-07-06 ms7000000619671915 来自广东省

想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回

40 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157808, encodeId=73ae215e80826, content=Initial technical check都21天了，还没有动静。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Iiaml2UbHXGORLCB6yjcA3siahzkAlrsL10ic5HpBKNzEaOJvOKpYqH5MWzYASOgMkP6AsOtibp1K0XXosBKjSA7sg/132, createdBy=c3382256530, createdName=喵喵.com, createdTime=Fri Sep 15 09:59:57 CST 2023, time=2023-09-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2144610, encodeId=049821446109e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析 经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Sun Jun 25 10:58:25 CST 2023, time=2023-06-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2176067, encodeId=55b921e6067a9, content=审稿速度:6.0 经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee235687562, createdName=ms9000001505387034, createdTime=Wed Dec 20 10:44:25 CST 2023, time=2023-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2146705, encodeId=39872146e05a1, content=想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26c88438756, createdName=ms7000000619671915, createdTime=Thu Jul 06 22:46:50 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2151710, encodeId=fa382151e103d, content=比较慢，并不是官方公布的那样。甚至第一关技术审查都不知道多久。着急的战友可绕道。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/14/b3e81e46eebeced4f1fa35ba3f571f1b.jpg, createdBy=eb0a2196272, createdName=湛湛518, createdTime=Tue Aug 08 00:41:04 CST 2023, time=2023-08-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1248225, encodeId=9acf1248225fe, content=请问更名后，检索得出来吗？推荐转投的，有点怕。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a7f5533568, createdName=韦钰, createdTime=Fri Sep 09 22:38:17 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174835, encodeId=16b621e483509, content=偏重的研究方向：肿瘤 经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd069039656, createdName=ms6000000198285398, createdTime=Thu Dec 14 00:06:56 CST 2023, time=2023-12-14, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2174396, encodeId=599521e4396eb, content=开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a24661695, createdName=liangshoulei, createdTime=Tue Dec 12 09:35:51 CST 2023, time=2023-12-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2161318, encodeId=48c02161318d8, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：审稿速度特慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Oct 07 12:04:42 CST 2023, time=2023-10-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=949365, encodeId=6c1094936573, content=已经更名为discovery oncology, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 18 22:08:28 CST 2021, time=2021-03-18, status=1, ipAttribution=)]

2023-08-08 湛湛518 来自福建省

比较慢，并不是官方公布的那样。甚至第一关技术审查都不知道多久。着急的战友可绕道。

47 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157808, encodeId=73ae215e80826, content=Initial technical check都21天了，还没有动静。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Iiaml2UbHXGORLCB6yjcA3siahzkAlrsL10ic5HpBKNzEaOJvOKpYqH5MWzYASOgMkP6AsOtibp1K0XXosBKjSA7sg/132, createdBy=c3382256530, createdName=喵喵.com, createdTime=Fri Sep 15 09:59:57 CST 2023, time=2023-09-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2144610, encodeId=049821446109e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析 经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Sun Jun 25 10:58:25 CST 2023, time=2023-06-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2176067, encodeId=55b921e6067a9, content=审稿速度:6.0 经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee235687562, createdName=ms9000001505387034, createdTime=Wed Dec 20 10:44:25 CST 2023, time=2023-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2146705, encodeId=39872146e05a1, content=想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26c88438756, createdName=ms7000000619671915, createdTime=Thu Jul 06 22:46:50 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2151710, encodeId=fa382151e103d, content=比较慢，并不是官方公布的那样。甚至第一关技术审查都不知道多久。着急的战友可绕道。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/14/b3e81e46eebeced4f1fa35ba3f571f1b.jpg, createdBy=eb0a2196272, createdName=湛湛518, createdTime=Tue Aug 08 00:41:04 CST 2023, time=2023-08-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1248225, encodeId=9acf1248225fe, content=请问更名后，检索得出来吗？推荐转投的，有点怕。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a7f5533568, createdName=韦钰, createdTime=Fri Sep 09 22:38:17 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174835, encodeId=16b621e483509, content=偏重的研究方向：肿瘤 经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd069039656, createdName=ms6000000198285398, createdTime=Thu Dec 14 00:06:56 CST 2023, time=2023-12-14, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2174396, encodeId=599521e4396eb, content=开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a24661695, createdName=liangshoulei, createdTime=Tue Dec 12 09:35:51 CST 2023, time=2023-12-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2161318, encodeId=48c02161318d8, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：审稿速度特慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Oct 07 12:04:42 CST 2023, time=2023-10-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=949365, encodeId=6c1094936573, content=已经更名为discovery oncology, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 18 22:08:28 CST 2021, time=2021-03-18, status=1, ipAttribution=)]

2022-09-09 韦钰

请问更名后，检索得出来吗？推荐转投的，有点怕。

42 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157808, encodeId=73ae215e80826, content=Initial technical check都21天了，还没有动静。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Iiaml2UbHXGORLCB6yjcA3siahzkAlrsL10ic5HpBKNzEaOJvOKpYqH5MWzYASOgMkP6AsOtibp1K0XXosBKjSA7sg/132, createdBy=c3382256530, createdName=喵喵.com, createdTime=Fri Sep 15 09:59:57 CST 2023, time=2023-09-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2144610, encodeId=049821446109e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析 经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Sun Jun 25 10:58:25 CST 2023, time=2023-06-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2176067, encodeId=55b921e6067a9, content=审稿速度:6.0 经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee235687562, createdName=ms9000001505387034, createdTime=Wed Dec 20 10:44:25 CST 2023, time=2023-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2146705, encodeId=39872146e05a1, content=想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26c88438756, createdName=ms7000000619671915, createdTime=Thu Jul 06 22:46:50 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2151710, encodeId=fa382151e103d, content=比较慢，并不是官方公布的那样。甚至第一关技术审查都不知道多久。着急的战友可绕道。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/14/b3e81e46eebeced4f1fa35ba3f571f1b.jpg, createdBy=eb0a2196272, createdName=湛湛518, createdTime=Tue Aug 08 00:41:04 CST 2023, time=2023-08-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1248225, encodeId=9acf1248225fe, content=请问更名后，检索得出来吗？推荐转投的，有点怕。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a7f5533568, createdName=韦钰, createdTime=Fri Sep 09 22:38:17 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174835, encodeId=16b621e483509, content=偏重的研究方向：肿瘤 经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd069039656, createdName=ms6000000198285398, createdTime=Thu Dec 14 00:06:56 CST 2023, time=2023-12-14, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2174396, encodeId=599521e4396eb, content=开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a24661695, createdName=liangshoulei, createdTime=Tue Dec 12 09:35:51 CST 2023, time=2023-12-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2161318, encodeId=48c02161318d8, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：审稿速度特慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Oct 07 12:04:42 CST 2023, time=2023-10-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=949365, encodeId=6c1094936573, content=已经更名为discovery oncology, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 18 22:08:28 CST 2021, time=2021-03-18, status=1, ipAttribution=)]

2023-12-14 ms6000000198285398 来自贵州省

偏重的研究方向：肿瘤
经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。

22 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157808, encodeId=73ae215e80826, content=Initial technical check都21天了，还没有动静。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Iiaml2UbHXGORLCB6yjcA3siahzkAlrsL10ic5HpBKNzEaOJvOKpYqH5MWzYASOgMkP6AsOtibp1K0XXosBKjSA7sg/132, createdBy=c3382256530, createdName=喵喵.com, createdTime=Fri Sep 15 09:59:57 CST 2023, time=2023-09-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2144610, encodeId=049821446109e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析 经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Sun Jun 25 10:58:25 CST 2023, time=2023-06-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2176067, encodeId=55b921e6067a9, content=审稿速度:6.0 经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee235687562, createdName=ms9000001505387034, createdTime=Wed Dec 20 10:44:25 CST 2023, time=2023-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2146705, encodeId=39872146e05a1, content=想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26c88438756, createdName=ms7000000619671915, createdTime=Thu Jul 06 22:46:50 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2151710, encodeId=fa382151e103d, content=比较慢，并不是官方公布的那样。甚至第一关技术审查都不知道多久。着急的战友可绕道。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/14/b3e81e46eebeced4f1fa35ba3f571f1b.jpg, createdBy=eb0a2196272, createdName=湛湛518, createdTime=Tue Aug 08 00:41:04 CST 2023, time=2023-08-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1248225, encodeId=9acf1248225fe, content=请问更名后，检索得出来吗？推荐转投的，有点怕。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a7f5533568, createdName=韦钰, createdTime=Fri Sep 09 22:38:17 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174835, encodeId=16b621e483509, content=偏重的研究方向：肿瘤 经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd069039656, createdName=ms6000000198285398, createdTime=Thu Dec 14 00:06:56 CST 2023, time=2023-12-14, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2174396, encodeId=599521e4396eb, content=开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a24661695, createdName=liangshoulei, createdTime=Tue Dec 12 09:35:51 CST 2023, time=2023-12-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2161318, encodeId=48c02161318d8, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：审稿速度特慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Oct 07 12:04:42 CST 2023, time=2023-10-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=949365, encodeId=6c1094936573, content=已经更名为discovery oncology, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 18 22:08:28 CST 2021, time=2021-03-18, status=1, ipAttribution=)]

2023-12-12 liangshoulei 来自河北省

开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！

31 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157808, encodeId=73ae215e80826, content=Initial technical check都21天了，还没有动静。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Iiaml2UbHXGORLCB6yjcA3siahzkAlrsL10ic5HpBKNzEaOJvOKpYqH5MWzYASOgMkP6AsOtibp1K0XXosBKjSA7sg/132, createdBy=c3382256530, createdName=喵喵.com, createdTime=Fri Sep 15 09:59:57 CST 2023, time=2023-09-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2144610, encodeId=049821446109e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析 经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Sun Jun 25 10:58:25 CST 2023, time=2023-06-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2176067, encodeId=55b921e6067a9, content=审稿速度:6.0 经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee235687562, createdName=ms9000001505387034, createdTime=Wed Dec 20 10:44:25 CST 2023, time=2023-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2146705, encodeId=39872146e05a1, content=想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26c88438756, createdName=ms7000000619671915, createdTime=Thu Jul 06 22:46:50 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2151710, encodeId=fa382151e103d, content=比较慢，并不是官方公布的那样。甚至第一关技术审查都不知道多久。着急的战友可绕道。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/14/b3e81e46eebeced4f1fa35ba3f571f1b.jpg, createdBy=eb0a2196272, createdName=湛湛518, createdTime=Tue Aug 08 00:41:04 CST 2023, time=2023-08-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1248225, encodeId=9acf1248225fe, content=请问更名后，检索得出来吗？推荐转投的，有点怕。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a7f5533568, createdName=韦钰, createdTime=Fri Sep 09 22:38:17 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174835, encodeId=16b621e483509, content=偏重的研究方向：肿瘤 经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd069039656, createdName=ms6000000198285398, createdTime=Thu Dec 14 00:06:56 CST 2023, time=2023-12-14, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2174396, encodeId=599521e4396eb, content=开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a24661695, createdName=liangshoulei, createdTime=Tue Dec 12 09:35:51 CST 2023, time=2023-12-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2161318, encodeId=48c02161318d8, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：审稿速度特慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Oct 07 12:04:42 CST 2023, time=2023-10-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=949365, encodeId=6c1094936573, content=已经更名为discovery oncology, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 18 22:08:28 CST 2021, time=2021-03-18, status=1, ipAttribution=)]

2023-10-07 124d2c45m98暂无昵称来自甘肃省

审稿速度:12.0 | 投稿命中率:5.0
经验分享：审稿速度特慢

33 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157808, encodeId=73ae215e80826, content=Initial technical check都21天了，还没有动静。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Iiaml2UbHXGORLCB6yjcA3siahzkAlrsL10ic5HpBKNzEaOJvOKpYqH5MWzYASOgMkP6AsOtibp1K0XXosBKjSA7sg/132, createdBy=c3382256530, createdName=喵喵.com, createdTime=Fri Sep 15 09:59:57 CST 2023, time=2023-09-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2144610, encodeId=049821446109e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析 经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Sun Jun 25 10:58:25 CST 2023, time=2023-06-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2176067, encodeId=55b921e6067a9, content=审稿速度:6.0 经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee235687562, createdName=ms9000001505387034, createdTime=Wed Dec 20 10:44:25 CST 2023, time=2023-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2146705, encodeId=39872146e05a1, content=想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26c88438756, createdName=ms7000000619671915, createdTime=Thu Jul 06 22:46:50 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2151710, encodeId=fa382151e103d, content=比较慢，并不是官方公布的那样。甚至第一关技术审查都不知道多久。着急的战友可绕道。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/14/b3e81e46eebeced4f1fa35ba3f571f1b.jpg, createdBy=eb0a2196272, createdName=湛湛518, createdTime=Tue Aug 08 00:41:04 CST 2023, time=2023-08-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1248225, encodeId=9acf1248225fe, content=请问更名后，检索得出来吗？推荐转投的，有点怕。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a7f5533568, createdName=韦钰, createdTime=Fri Sep 09 22:38:17 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174835, encodeId=16b621e483509, content=偏重的研究方向：肿瘤 经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd069039656, createdName=ms6000000198285398, createdTime=Thu Dec 14 00:06:56 CST 2023, time=2023-12-14, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2174396, encodeId=599521e4396eb, content=开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a24661695, createdName=liangshoulei, createdTime=Tue Dec 12 09:35:51 CST 2023, time=2023-12-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2161318, encodeId=48c02161318d8, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：审稿速度特慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Oct 07 12:04:42 CST 2023, time=2023-10-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=949365, encodeId=6c1094936573, content=已经更名为discovery oncology, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 18 22:08:28 CST 2021, time=2021-03-18, status=1, ipAttribution=)]

2021-03-18 1465389cm38暂无昵称

已经更名为discovery oncology

173 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务